|
SNX3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.31760047317186E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.97779999547387E-08 |
| Normal-vs-Stage2 |
1.097800E-01 |
| Normal-vs-Stage3 |
2.68485234045102E-12 |
| Normal-vs-Stage4 |
5.26845234105622E-12 |
| Stage1-vs-Stage2 |
3.681400E-01 |
| Stage1-vs-Stage3 |
4.144200E-03 |
| Stage1-vs-Stage4 |
1.100210E-03 |
| Stage2-vs-Stage3 |
3.107900E-02 |
| Stage2-vs-Stage4 |
1.746410E-02 |
| Stage3-vs-Stage4 |
6.338000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.48020542676409E-11 |
| Normal-vs-AfricanAmerican |
2.099700E-03 |
| Normal-vs-Asian |
3.69350000000157E-05 |
| Caucasian-vs-AfricanAmerican |
9.928200E-01 |
| Caucasian-vs-Asian |
6.433000E-01 |
| AfricanAmerican-vs-Asian |
7.401400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.72245999999765E-05 |
| Normal-vs-Female |
6.73270328377384E-11 |
| Male-vs-Female |
5.316800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.49540000005111E-06 |
| Normal-vs-Age(41-60Yrs) |
2.30270025269874E-10 |
| Normal-vs-Age(61-80Yrs) |
3.30500000034206E-07 |
| Normal-vs-Age(81-100Yrs) |
1.031770E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.910000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.330800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.920600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.855600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.912600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.876400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.079600E-02 |
| Classical-VS-Follicular |
2.124800E-01 |
| Classical-VS-Other |
5.046800E-01 |
| Classical-VS-Normal |
1.64519997625234E-09 |
| Tall-VS-Follicular |
1.011860E-02 |
| Tall-VS-Other |
3.358800E-01 |
| Tall-VS-Normal |
2.19450002614252E-09 |
| Follicular-VS-Other |
6.382600E-01 |
| Follicular-VS-Normal |
2.256500E-03 |
| Other-VS-Normal |
9.368800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.3866000054571E-08 |
| Normal-vs-N1 |
4.4773962315503E-11 |
| N0-vs-N1 |
3.975400E-03 |
|
|
